As of 2024-12-12, the Relative Valuation of Organogenesis Holdings Inc (ORGO) is 0.57 USD. This relative valuation is based on P/E multiples. With the latest stock price at 3.66 USD, the upside of Organogenesis Holdings Inc based on Relative Valuation is -84.5%.
The range of the Relative Valuation is (0.99) - 2.62 USD.
| Range | Selected | |
| Trailing P/E multiples | 17.8x - 24.8x | 20.8x |
| Forward P/E multiples | 22.7x - 27.5x | 24.0x |
| Fair Price | (0.99) - 2.62 | 0.57 |
| Upside | -127.0% - -28.4% | -84.5% |
| Date | P/E |
| 2024-12-09 | -63.33 |
| 2024-12-06 | -66.11 |
| 2024-12-05 | -64.49 |
| 2024-12-04 | -68.45 |
| 2024-12-03 | -71.32 |
| 2024-12-02 | -69.34 |
| 2024-11-29 | -69.52 |
| 2024-11-27 | -70.06 |
| 2024-11-26 | -71.14 |
| 2024-11-25 | -72.58 |
| 2024-11-22 | -72.76 |
| 2024-11-21 | -72.22 |
| 2024-11-20 | -71.32 |
| 2024-11-19 | -73.30 |
| 2024-11-18 | -70.78 |
| 2024-11-15 | -69.34 |
| 2024-11-14 | -71.95 |
| 2024-11-13 | -79.58 |
| 2024-11-12 | -61.98 |
| 2024-11-11 | -62.88 |
| 2024-11-08 | -58.92 |
| 2024-11-07 | -58.57 |
| 2024-11-06 | -57.67 |
| 2024-11-05 | -54.61 |
| 2024-11-04 | -53.71 |
| 2024-11-01 | -49.94 |
| 2024-10-31 | -49.76 |
| 2024-10-30 | -51.92 |
| 2024-10-29 | -53.54 |
| 2024-10-28 | -53.00 |
| 2024-10-25 | -50.30 |
| 2024-10-24 | -51.56 |
| 2024-10-23 | -51.92 |
| 2024-10-22 | -55.69 |
| 2024-10-21 | -55.87 |
| 2024-10-18 | -56.77 |
| 2024-10-17 | -55.15 |
| 2024-10-16 | -58.39 |
| 2024-10-15 | -57.49 |
| 2024-10-14 | -55.51 |
| 2024-10-11 | -55.15 |
| 2024-10-10 | -52.10 |
| 2024-10-09 | -54.25 |
| 2024-10-08 | -53.71 |
| 2024-10-07 | -53.71 |
| 2024-10-04 | -55.33 |
| 2024-10-03 | -51.38 |
| 2024-10-02 | -51.20 |
| 2024-10-01 | -50.66 |
| 2024-09-30 | -51.38 |